Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.56 -0.24 (-0.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Free Cash Flow (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Free Cash Flow was $307 million in Q2 2026, up 134.4% from $131 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Free Cash Flow (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Teva Pharmaceutical Industries' Free Cash Flow was $1.35 billion through Jun 30, 2026, up 51.5% year-over-year; for FY2025, it came in at $1.15 billion, up 53.3% from FY2024.

  • Free Cash Flow shows a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
  • In earlier years, Free Cash Flow was $749 million in FY2024 (-11.0%), $842 million in FY2023 (-19.2%), $1.04 billion in FY2022 (+341.5%) and $236 million in FY2021 (-63.0%).
  • Quarterly Free Cash Flow has moved between -$284 million (Q1 2023) and $1.07 billion (Q4 2023) over five years.
  • Compared with a year earlier, Free Cash Flow was higher in two of the last four quarters, with growth averaging 36.7%.
  • The best year-over-year quarter for Free Cash Flow over five years was Q4 2022 (growth of 174.3%); the worst was Q2 2024 (a decline of 97.1%).
  • Per Business Quant data, TEVA's Free Cash Flow in the three quarters before Q2 2026 was -$208 million (Q1 2026), $1.02 billion (Q4 2025) and $233 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Teva Pharmaceutical Industries 46.10 Bn 32.95 Bn 2.15 Bn 307.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 307.00 Mn
Mar 31, 2026 -208.00 Mn
Dec 31, 2025 1.02 Bn
Sep 30, 2025 233.00 Mn
Jun 30, 2025 131.00 Mn
Mar 31, 2025 -232.00 Mn
Dec 31, 2024 446.00 Mn
Sep 30, 2024 545.00 Mn
Jun 30, 2024 6.00 Mn
Mar 31, 2024 -248.00 Mn
Dec 31, 2023 1.07 Bn
Sep 30, 2023 -144.00 Mn
Jun 30, 2023 205.00 Mn
Mar 31, 2023 -284.00 Mn
Dec 31, 2022 831.00 Mn
Sep 30, 2022 421.00 Mn
Jun 30, 2022 -4.00 Mn
Mar 31, 2022 -206.00 Mn
Dec 31, 2021 303.00 Mn
Sep 30, 2021 383.00 Mn
API Access

Teva Pharmaceutical Industries Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=TEVA&period=max&api_key=YOUR_API_KEY